Compare Eaton Corporation plc (ETN) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Natera Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $400.49 (market cap $158.80B), while Natera Inc. Common Stock trades at $392.66 (market cap $57.03B). The key difference: Eaton Corporation plc is far larger — about 2.8× Natera Inc. Common Stock's market cap, and Eaton Corporation plc pays a 1.08% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 32 Days and Natera Inc. Common Stock for 0 Days on average.
| ETN | NTRA | |
|---|---|---|
Market Cap | $158.80B | $57.03B |
Volume | 3,207,896 | 1,131,157 |
Sector | Industrials | Health |
52-Week High | $459.96 | $425.64 |
52-Week Low | $315.82 | $179.42 |
Typical Hold Time | 32 Days | 0 Days |
Enterprise Value | $179.43B | $56.18B |
Dividend Yield | 1.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $428.31, up 0.38% with neutral technical signals. The company demonstrates strong fundamentals with consistent earnings beats and robust profitability (ROE 19.71%, net margin 12.75%). Recent acquisitions in data center and grid modernization sectors position ETN for durable growth, supported by a $502.38 consensus price target and unanimous analyst buy/hold recommendations.
ETN presents a compelling investment case with strong earnings momentum and strategic positioning in high-growth markets. Key risks include execution of acquisition strategy and competitive pressures in the electrical equipment sector. The stock trades at premium valuations (P/E 41.63) but offers 17% upside to analyst targets, supported by solid cash flow generation and dividend payments.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
